In Australia’s health and wellness landscape, intermittent fasting has emerged as one of the most discussed dietary approaches. With promises of weight management, improved metabolic health, and even longevity benefits, the appeal is understandable. Yet, while social media influencers and certain health professionals tout its universal benefits, scientific evidence paints a more nuanced picture. The fundamental question—does intermittent fasting work for everyone?—requires careful examination beyond the popular headlines.
What Is Intermittent Fasting and How Does It Actually Work?
Intermittent fasting (IF) isn’t a diet in the traditional sense but rather a pattern of eating that alternates between periods of voluntary fasting and eating. Common approaches include time-restricted eating (such as the 16:8 method), alternate-day fasting, and the 5:2 method (fasting or severely restricting calories for two non-consecutive days each week).
The scientific mechanism behind intermittent fasting centres on “metabolic switching”—the body’s transition from glucose-dependent energy production to ketone metabolism during fasting periods. This shift activates several physiological processes:
- Decreased insulin levels, allowing stored fat to become more accessible for energy
- Increased norepinephrine, which enhances fat breakdown
- Activation of cellular repair mechanisms, including autophagy
- Mitochondrial biogenesis and reduced oxidative stress
While these mechanisms are well-documented in controlled studies, the degree to which they manifest varies significantly between individuals. Research indicates that factors such as genetic predisposition, baseline metabolic health, and even gut microbiome composition can influence how effectively one’s body responds to fasting protocols.
How Effective Is Intermittent Fasting for Weight Loss?
Clinical trials consistently demonstrate that intermittent fasting can facilitate weight loss, though the magnitude varies considerably. Short-term studies report average reductions of 3–8% of baseline body weight, primarily through fat mass reduction.
| Fasting Protocol | Average Weight Loss (3 months) | Metabolic Improvements | Adherence Rate (6 months) |
|---|---|---|---|
| Time-Restricted Eating (16:8) | 3-4% | Modest improvements in insulin sensitivity | 56% |
| Modified Alternate-Day Fasting | 4-7% | Reduced LDL (14%), triglycerides (22%) | 44% |
| 5:2 Diet | 3-5% | Improved glycemic control (HbA1c ↓ 0.5%) | 48% |
| Extended Fasting (>24h) | 4-8% | Significant insulin reduction, ketosis | 22% |
However, long-term efficacy remains uncertain. A 2023 University of Sydney randomised controlled trial found that while participants lost weight with time-restricted eating, they showed no significant improvements in inflammatory markers or overall metabolic health compared to those on standard calorie-restricted diets.
Most notably, weight loss results plateau after approximately 12 months in longitudinal studies, suggesting diminishing returns with prolonged adherence—a finding that contradicts claims of sustained, progressive benefits.
Do Men and Women Respond Differently to Intermittent Fasting?
One of the most significant variables in intermittent fasting effectiveness is biological sex. Research consistently shows pronounced differences in how men and women respond to fasting protocols.
Women appear more susceptible to hormonal disruptions during fasting periods. A 2022 University of Illinois Chicago study documented a 12% decline in dehydroepiandrosterone (DHEA)—a hormone critical for reproductive function—among pre- and postmenopausal women following a 4-hour eating window protocol. Conversely, male participants maintained stable reproductive hormone levels while achieving greater fat mass reduction.
These sex-specific differences likely stem from evolutionary adaptations. Female physiology appears to prioritise reproductive resilience over rapid weight loss during periods of caloric restriction, a protective mechanism that can limit fat loss efficiency compared to male counterparts.
For women with existing hormonal imbalances, including polycystic ovary syndrome (PCOS) or thyroid disorders, intermittent fasting may exacerbate symptoms rather than alleviate them. This highlights the importance of personalised approaches rather than one-size-fits-all recommendations.
How Does Age Affect Intermittent Fasting Results?
Age represents another crucial factor in determining intermittent fasting outcomes. The research shows distinct patterns across different life stages:
Young Adults (18-30)
While intermittent fasting is generally well-tolerated in this group, it remains contraindicated for those under 18 due to potential disruptions in growth hormone patterns and neurodevelopment. Young adults typically show positive metabolic responses but may struggle with adherence due to social factors.
Middle-Aged Adults (30-65)
This demographic often demonstrates the most favourable risk-benefit profile for intermittent fasting, particularly those with excess weight or early metabolic dysfunction. Improved insulin sensitivity and modest weight loss are commonly reported outcomes.
Older Adults (65+)
Research raises significant concerns about intermittent fasting in older populations. A 2023 meta-analysis cautioned that adults over 65 face accelerated muscle loss unless protein intake and resistance training are prioritised alongside fasting protocols. Given that sarcopenia (age-related muscle loss) contributes to frailty and mortality in older adults, this risk cannot be overlooked.
Additionally, older adults may experience more pronounced side effects, including orthostatic hypotension, electrolyte imbalances, and increased fall risk during fasting periods—complications that rarely affect younger practitioners.
What Health Conditions Might Benefit or Worsen with Intermittent Fasting?
The impact of intermittent fasting varies dramatically depending on pre-existing health conditions, making personalised medical assessment essential.
Potentially Beneficial Conditions
- Type 2 diabetes: Multiple studies document improved glycemic control with supervised intermittent fasting, with HbA1c reductions of approximately 0.5% over six months
- Non-alcoholic fatty liver disease (NAFLD): Research shows reduced hepatic steatosis (up to 25% reduction on ultrasound) after three months of alternate-day fasting
- Hypertension: Modest reductions in systolic blood pressure (average 6 mmHg) observed in clinical trials
Conditions Requiring Caution
- Type 1 diabetes or insulin-dependent Type 2 diabetes: Increased risk of hypoglycemia during fasting periods
- Gastroesophageal reflux disease (GERD): Fasting can exacerbate symptoms as stomach acid production increases by up to 40% in the absence of food
- History of eating disorders: 38% of participants in a 2024 survey reported post-fast overeating behaviours, suggesting potential triggering effects
Contraindicated Conditions
- Pregnancy and lactation: Risk of nutrient deficiency and impaired development
- Kidney stones or chronic kidney disease: Heightened risk of hyperuricemia and urate crystalluria
- Active growth phases (children/adolescents): Potential disruption of critical developmental processes
Who Should Avoid Intermittent Fasting Altogether?
While intermittent fasting may benefit certain populations, compelling evidence indicates it is unsuitable or potentially harmful for several groups:
- Pregnant or breastfeeding women: The additional nutritional demands of pregnancy and lactation make fasting contraindicated.
- Individuals with eating disorders or their history: The restrictive nature of IF can trigger or exacerbate disordered eating patterns.
- Children and adolescents: Developing bodies require consistent nutrition for optimal growth and development.
- People with certain medical conditions: This includes those with insulin-dependent diabetes, adrenal insufficiency, or advanced liver or kidney disease.
- Individuals taking specific medications: Many pharmaceuticals require consistent food intake for proper absorption and effectiveness.
- Underweight individuals: Those with BMI below healthy ranges should focus on nutritional adequacy rather than restriction.
The evidence underscores that intermittent fasting is not a universal solution—rather, it represents one approach among many that may benefit specific populations while potentially harming others.
The Balanced Perspective on Intermittent Fasting
Intermittent fasting offers a viable weight management strategy for many—particularly metabolically healthy adults with excess weight. The scientific literature confirms modest benefits for cardiometabolic health in the short to medium term for appropriate candidates.
However, its effectiveness varies dramatically based on individual factors including sex, age, genetic predisposition, and pre-existing health conditions. High dropout rates (up to 56% within six months) further highlight challenges with long-term adherence and sustainability.
For those who find intermittent fasting incompatible with their physiology or lifestyle, evidence-based alternatives exist. These include traditional calorie restriction, Mediterranean dietary patterns, or medically supervised weight management programs that provide structured support and personalised approaches.
The science is clear: intermittent fasting works for some people, but definitely not for everyone. Individual assessment, preferably with healthcare guidance, remains essential for optimal outcomes and safety.
Skip the struggles. our patients achieve <20.2% weight reduction with medical weight loss treatments delivered straight to their door. No clinics. No waiting. Just results. See if you’re eligible for our medical weight loss treatments – take our quiz.
